Close Menu

The Scientist profiles Aaron Chiechanover, who shared the 2004 Nobel Prize in Chemistry for the discovery of ubiquitin-mediated protein degradation ― a determination he made as part of his PhD thesis. “We didn’t set out to identify ubiquitin. We didn’t know anything about ubiquitin or its function,” Ciechanover tellsThe Scientist. “We were studying intracellular proteolysis and we bumped into it.”

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.